Investor Relations

The primary objective of our Investor Relations activities is to communicate with the financial community, especially private as well as institutional investors and analysts, in an open and timely manner. Our focus is on conducting a correct, comprehensive and fair dialogue.
IR EVENT
January 19, 2010
   
pdf_CA Cheuvreux German Corporate Conference (528 kb)
> More meetings
PRESENTATION OF FINANCIAL RESULTS   
October 26, 2009
    
pdf Results 3rd Quarter 2009 (1.2 MB)
> Results of prior quarters
Dr. Michael Becker
"Merck is an innovative pharmaceutical and chemical company with a portfolio of complementary business dynamics that will drive the quality growth of the Group going forward."
Dr. Michael Becker

IR NEWS

11/30/2009
Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application

UPCOMING DATES

02/23/2010
Publication of business results for Q4 / FY 2009 (Analysts Conference)